Tender detail

Anaesthetics and muscle relaxants

Summary

The procurement seeks a framework agreement for the purchase of anaesthetics and muscle relaxants in 29 lots. Bids may be submitted for up to all 29 lots. Medicines must be delivered, including unloading, to the pharmacy of Tartu University Hospital in Tartu and the pharmacy of Põlva Hospital in Põlva. Each bid must meet the technical requirements for the relevant lot and state the medicine’s active substance, original product name, pharmaceutical form, dose, manufacturer, unit price and total price. Prices must be quoted in euros and include all delivery and unloading costs; unit prices are final. The bidder must submit a participation declaration and hold an Estonian wholesale authorisation for medicines. Each offered medicine must have a valid marketing authorisation in Estonia or a relevant professional association application; the contracting authority will verify the licences in the relevant registers. Where several businesses submit a joint bid, they must provide a power of attorney and confirmation of joint and several liability.

Reference number
315950-0000
Buyer
sihtasutus Tartu Ülikooli Kliinikum
Country
Estonia (EST)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2026-10-28
Status
Open
Contract subject
Supplies
Estimated value
Not published
Source
RHR

Participation requirements

Tender requirements are available in the official tender documents.

Compliance requirements

The bidder must confirm that it and its relevant representatives have not been convicted within the applicable period for participation in a criminal organisation, corruption, fraud, terrorist offences, money laundering or terrorist financing, child labour or human trafficking. Exclusion grounds also cover unpaid taxes or social security contributions; insolvency, bankruptcy, liquidation, creditor arrangements or suspended business activities; serious professional misconduct; agreements intended to distort competition; conflicts of interest or involvement in preparing the procurement that cannot otherwise be remedied; serious or repeated breaches of earlier contracts; false or misleading information, failure to provide required information or documents, or attempts to obtain confidential information improperly; environmental, social or labour-law breaches; enabling the unlawful employment of a foreign national; international sanctions; and convictions for tax offences. For tax debts, the notice states a threshold of EUR 0 and explains that debts below EUR 100 may not result in a debt certificate where the debt is deferred. Where legally available, the bidder may provide evidence of remedial measures restoring its reliability. The grounds apply to all lots.

Qualification criteria and exclusion grounds

The bidder must hold an Estonian authorisation to wholesale medicines and confirm this in the participation declaration; the contracting authority will check it in the relevant register. Each offered medicine must have a valid marketing authorisation in Estonia, confirmed in the declaration. If the medicine lacks an Estonian marketing authorisation or a relevant professional association application, the contracting authority will apply to the State Agency of Medicines for its import. Submit the participation declaration (Annex 4, Form II) and a technically compliant offer using Annex 1 in Excel format, specifying the active substance, original product name, pharmaceutical form, offered dose, manufacturer, unit price and total price. Prices must be in euros, include delivery and unloading to both specified hospital pharmacies, and be final. Confirm compliance with the tender documents; if offering an equivalent, explain the equivalence and provide supporting evidence. Confirm that the goods are not subject to international sanctions or from sanctioned regions. Do not use subcontractors or suppliers covered by the stated Russian sanctions restrictions for more than 10% of the contract value. Joint bidders must appoint an authorised representative and submit the power of attorney and joint-and-several liability confirmation using Annex 4, Form I. Identify and justify any claimed trade secrets; prices and price components cannot be treated as trade secrets.